3176 results for «372»

Filter By

3176 results

Severe mitral and tricuspid regurgitation

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session aims to illustrate the role of mitral TEER in patients with significant MR and cardiogenic shock, to demonstrate the importance of early detection, but also to show that earlier referral and treatment of patients with significant TR is essential to prevent patients...

Severe mitral and tricuspid regurgitation

Gulf WIN - Opportunities and challenges

15 Dec 2022 – From GulfPCR-GIM 2022

Women have the floor in this special GulfPCR-GIM 2022 session: hear from members of the Gulf WIN (Women In Intervention) to better understand the status of women interventionists in the region, explore the challenges they face, and note the differences that exist with other women cardiologists...

Gulf WIN - Opportunities and challenges

Optimal management of a patient with calcified lesions - Session with LIVE case

15 Dec 2022 – From GulfPCR-GIM 2022

Watch the case of an 87-year-old male patient with DM, HTN, and hyperlipidemia, who suffered ACS six weeks ago, whose culprit lesions were treated in the RCA and LCX, and who was incidentally readmitted for LAD PCI, and find out how he was treated LIVE.

Optimal management of a patient with calcified lesions

Essential drugs that every interventionalist needs to know

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, learn about the role of PCSK9 inhibitors in ACS and post-PCI patients, the role of SGLT2 receptor blockers and GLP RAs, and the role of P2Y12 inhibitors as unique post-PCI antiplatelet agents.

Essential drugs that every interventionalist needs to know

CABG vs. PCI - Multivessel disease

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this GulfPCR-GIM 2022 session to find out more about the guidelines in revascularisation for multivessel disease, simplification of multivessel disease PCI using physiological guidance, and much more!

CABG vs. PCI - Multivessel disease

All you need to know on physiology: a 2023 update

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, listen to William Wijns discuss the following physiology topics: long-term data on PCI deferral, update on new "negative" studies, low adoption in daily practice, and computational image-based physiology.    

All you need to know on physiology: a 2023 update

Challenging and complication cases

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this GulfPCR-GIM 2022 session to learn how to deal with post-infarction ventricular rupture, an unusual post-CABG complication, a left main complication with the LACOSTE technique, the entrapment of a knotted catheter in the radial artery during primary PCI, and much more!

Challenging and complication cases

GulfPCR-GIM 2022 - Closing Ceremony

15 Dec 2022 – From GulfPCR-GIM 2022

Listen to the Course Directors thank all the participants and take stock of this 2022 edition, insisting in particular on the role of imaging, which must not however make us forget the basics of interventional cardiology, before attending the prize-giving ceremony for the best clinical cases...

GulfPCR-GIM 2022 - Closing Ceremony

STEMI - Tools, devices and techniques

15 Dec 2022 – From GulfPCR-GIM 2022

Among the 4 GulfPCR-GIM 2022 cases presented in this session, discover a curious case of type 4 dual left anterior descending artery presenting with STEMI, or an inferior wall STEMI with complete heart block in anomalous right coronary artery.

STEMI - Tools, devices and techniques

Rapid-fire clinical cases: Session 7

29 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: simultaneous transcatheter edge-to-edge repair of mitral and tricuspid valve, transcatheter valve implantation in mitral and tricuspid valve position, TEER failure in mitral and tricuspid position: troubleshooting approach for a rare but still eventful case,...

Rapid-fire clinical cases: Session 7

Rapid-Fire clinical cases: Session 3

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of clinical cases presented during PCR LV 2022: tunnel stent technique as an alternative treatment for left main protection in valve-in-valve TAVI, coronary embolisation due to valve-in-valve aortic prothesis thrombosis, aortic prosthetic valve dysfunction due to endocarditis, and more!

Rapid-Fire clinical cases: Session 3

Coronary sinus reducer for microvascular angina

28 Feb 2020

A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...

Coronary sinus reducer for microvascular angina

Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial

26 Oct 2023

Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3

02 Apr 2025

Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
FFR-guided PCI vs CABG: 5-year results of the FAME 3 trial

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
Didn’t find what you were looking for?